Paper29282012
Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Maningi NE and 4 others. BMC Infect Dis, 2017. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa. Papers, record 29282012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29282012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antitubercular Agents | Major topic |
| Microbial Sensitivity Tests | Major topic |
| Mycobacterium tuberculosis | Major topic |
| DNA, Bacterial | |
| Ethambutol | |
| Female | |
| Genotype | |
| Humans | |
| Isoniazid | |
| Kanamycin | |
| Laboratories | |
| Male | |
| Ofloxacin | |
| Referral and Consultation | |
| Rifampin | |
| South Africa |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24648563 | Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United States. | J Clin Microbiol | 2014 | https://conductscience.org/library/papers/24648563 | PubMed |
| 2 | 23640554 | Tuberculosis: From an incurable scourge to a curable disease - journey over a millennium. | Indian J Med Res | 2013 | https://conductscience.org/library/papers/23640554 | PubMed |
| 3 | 27345127 | Performance of the MTBDRsl Line probe assay for rapid detection of resistance to second-line anti-tuberculosis drugs and ethambutol in China. | Diagn Microbiol Infect Dis | 2017 | https://conductscience.org/library/papers/27345127 | PubMed |
| 4 | 28100546 | Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis. | Eur Respir J | 2017 | https://conductscience.org/library/papers/28100546 | PubMed |
| 5 | 22236920 | Rise in rifampicin-monoresistant tuberculosis in Western Cape, South Africa. | Int J Tuberc Lung Dis | 2012 | https://conductscience.org/library/papers/22236920 | PubMed |
| 6 | 27865394 | Recent developments in genomics, bioinformatics and drug discovery to combat emerging drug-resistant tuberculosis. | Tuberculosis (Edinb) | 2016 | https://conductscience.org/library/papers/27865394 | PubMed |
| 7 | 27974543 | Evaluation of the GenoType MTBDRsl Version 2.0 Assay for Second-Line Drug Resistance Detection of Mycobacterium tuberculosis Isolates in South Africa. | J Clin Microbiol | 2017 | https://conductscience.org/library/papers/27974543 | PubMed |
| 8 | 20335420 | Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. | J Clin Microbiol | 2010 | https://conductscience.org/library/papers/20335420 | PubMed |
| 9 | 24172155 | Discordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory. | J Clin Microbiol | 2014 | https://conductscience.org/library/papers/24172155 | PubMed |
| 10 | 18272712 | Spread of a low-fitness drug-resistant Mycobacterium tuberculosis strain in a setting of high human immunodeficiency virus prevalence. | J Clin Microbiol | 2008 | https://conductscience.org/library/papers/18272712 | PubMed |
| 11 | 16825369 | Use of genotype MTBDR assay for molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis clinical strains isolated in Italy. | J Clin Microbiol | 2006 | https://conductscience.org/library/papers/16825369 | PubMed |
| 12 | 25129689 | Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa. | BMC Infect Dis | 2014 | https://conductscience.org/library/papers/25129689 | PubMed |
| 13 | 24599230 | Correlation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility results. | PLoS One | 2014 | https://conductscience.org/library/papers/24599230 | PubMed |
| 14 | 22075601 | The beginning of the rpoB gene in addition to the rifampin resistance determination region might be needed for identifying rifampin/rifabutin cross-resistance in multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. | J Clin Microbiol | 2012 | https://conductscience.org/library/papers/22075601 | PubMed |
| 15 | 27994580 | Correlation of rpoB Mutations with Minimal Inhibitory Concentration of Rifampin and Rifabutin in Mycobacterium tuberculosis in an HIV/AIDS Endemic Setting, South Africa. | Front Microbiol | 2016 | https://conductscience.org/library/papers/27994580 | PubMed |
| 16 | 19759221 | Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. | J Clin Microbiol | 2009 | https://conductscience.org/library/papers/19759221 | PubMed |
| 17 | 28415989 | Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples. | BMC Infect Dis | 2017 | https://conductscience.org/library/papers/28415989 | PubMed |
| 18 | 25008829 | Evaluation of the GenoType MTBDR assay for detection of rifampicin and isoniazid resistance in Mycobacterium tuberculosis complex isolates. | Indian J Med Microbiol | 2014 | https://conductscience.org/library/papers/25008829 | PubMed |
| 19 | 20477293 | Rapid diagnosis of drug-resistant TB using line probe assays: from evidence to policy. | Expert Rev Respir Med | 2008 | https://conductscience.org/library/papers/20477293 | PubMed |
| 20 | 23883707 | Use of GenoType® MTBDRplus assay to assess drug resistance and mutation patterns of multidrug-resistant tuberculosis isolates in northern India. | Indian J Med Microbiol | 2013 | https://conductscience.org/library/papers/23883707 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41102624 | Predisposing, enabling, and need factors influencing rapid uptake of the world health organization-endorsed TB diagnostic technologies in Africa. | BMC Infect Dis | 2025 | https://conductscience.org/library/papers/41102624 | PubMed |
| 39770305 | Strategies to Enhance Diagnostic Capabilities for the New Drug-Resistant Tuberculosis (DR-TB) Drugs. | Pathogens | 2024 | https://conductscience.org/library/papers/39770305 | PubMed |
| 39663850 | Diagnostic Accuracy of LiquidArray MTB-XDR VER 1.0 for the Detection of Mycobacterium tuberculosis Complex, Fluoroquinolone, Amikacin, Ethambutol, and Linezolid Susceptibility. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/39663850 | PubMed |
| 38012619 | Phenotypic drug susceptibility characterization and clinical outcomes of tuberculosis strains with A-probe mutation by GeneXpert MTB/RIF. | BMC Infect Dis | 2023 | https://conductscience.org/library/papers/38012619 | PubMed |
| 37753014 | Drug Resistance in Osteoarticular Tuberculosis: A Study From an Endemic Zone. | Cureus | 2023 | https://conductscience.org/library/papers/37753014 | PubMed |
| 36767896 | Novel Mutations in MPT64 Secretory Protein of Mycobacterium tuberculosis Complex. | Int J Environ Res Public Health | 2023 | https://conductscience.org/library/papers/36767896 | PubMed |
| 36554951 | Evaluation Study of xMAP TIER Assay on a Microsphere-Based Platform for Detecting First-Line Anti-Tuberculosis Drug Resistance. | Int J Environ Res Public Health | 2022 | https://conductscience.org/library/papers/36554951 | PubMed |
| 35541502 | Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis strains in geriatrics: An analysis and its implications in tuberculosis control. | J Clin Tuberc Other Mycobact Dis | 2022 | https://conductscience.org/library/papers/35541502 | PubMed |
| 34914803 | Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh. | PLoS One | 2021 | https://conductscience.org/library/papers/34914803 | PubMed |
| 33833390 | Increasing prevalence of resistance to second-line drugs among multidrug-resistant Mycobacterium tuberculosis isolates in Kuwait. | Sci Rep | 2021 | https://conductscience.org/library/papers/33833390 | PubMed |
| 33284842 | Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia. | PLoS One | 2020 | https://conductscience.org/library/papers/33284842 | PubMed |
| 33061477 | The Performance of the Abbott Real Time MTB RIF/INH Compared to the MTBDRplus V2 for the Identification of MDR-TB Among Isolates. | Infect Drug Resist | 2020 | https://conductscience.org/library/papers/33061477 | PubMed |
| 32311949 | Mycobacterium culturing and drug resistance of osteoarticular tuberculosis in Xinjiang, China. | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/32311949 | PubMed |
| 30531026 | Meta-narrative review of molecular methods for diagnosis and monitoring of multidrug-resistant tuberculosis treatment in adults. | Int J Mycobacteriol | 2018 | https://conductscience.org/library/papers/30531026 | PubMed |
| 30319279 | Evaluation of the GenoType MTBDRplus and MTBDRsl for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Beijing, China. | Infect Drug Resist | 2018 | https://conductscience.org/library/papers/30319279 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| LPA | 4018 | PubTator's text mining | https://conductscience.org/library/genes/4018 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29282012
GET https://conductscience.org/api/papers/v1/29282012/references?page=2